Wall Street Grows Wary as Fed Rate Hike Concerns Resurface NextNRG NXXT Gains Attention as Renewable Energy Sector Seeks New Growth Drivers Navitas NVTS Crushes Q1 2026 Estimates EPS 004 Tops Views Reed Jobs 1bn Yosemite Fund Eyes UK Cancer Care Opportunities SpaceX IPO Opens to Retail Investors Through Major Brokerage Platforms IKEI 2026 MA Review First Four Months Signal Cautious Deal Activity US Dollar Strengthens to Near SixWeek High Amid Rising Geopolitical Tensions with Iran SpaceX IPO Faces Caution as Market Analysts Flag Key Risks UBS Raises SP 500 YearEnd Forecast Citing Strong Consumer Spending and AI Demand Gunnison Copper Secures Refundable Tax Credit from Arizona Commerce Authority for Domestic Copper Production CODI Q1 2026 Earnings Stunning EPS Beat Masks Broader Market Concerns Amer Sports Inc Q1 2026 Earnings EPS Beats Estimates by 211 Stock Holds Steady SMTC Q1 2026 Earnings EPS Surges 106 Above Estimates Yet Stock Slides 44 FBLG Q1 2026 Earnings Narrowly Misses EPS Estimates No Revenue Reported Edgewell Personal Care Company EPC Q1 2026 Earnings EPS Misses Estimates Amidst Operational Challenges Stock Edges Higher GBFH Q1 2026 Earnings EPS Falls Sharply Below Estimates Stock Retreats Republic Digital Acquisition Unit RDAGU Holds at 1055 as SPAC Unit Trades in Tight Range Viant Technology DSP Edges Lower Holds Above Key Support Level Air Lease Corporation Holds Steady at 6500 as Key Support and Resistance Levels Remain in Focus Arbutus Biopharma ABUS Dips 2 Testing Key Support Levels Amid Modest Trading Volume Psyence Biomedical Ltd PBM Slips 56 as Shares Test Key Support Level Corcept Therapeutics CORT Holds Near Support Amid Modest Gains Resistance at 6287 in Focus iSpecimen ISPC Shows Resilience Up 59 as Buyers Defend Key Support Infosys INFY Edges Higher as Support Holds Key Levels to Watch Telomir Pharmaceuticals TELO Trades Near Support at 121 After Slight Decline Ingevity Corporation NGVT Gains 279 as Stock Climbs Toward Key Resistance SpaceX and OpenAI IPOs Could Amplify AI Valuation Concerns Analysts Suggest ISBA Q1 2026 Earnings Significant EPS Miss Amid Challenging Quarter Polaryx Therapeutics PLYX Slips 863 as Biotech Volatility Resurfaces Key Support Levels in Focus